Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation. (Q37928952)

From Wikidata

Jump to navigation Jump to search

scientific article published on 07 September 2011

Language	Label	Description	Also known as
English	Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation.	scientific article published on 07 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

organ transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Gyula Végso

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dénes Görög

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Balázs Nemes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Attila Doros

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Róbert Miklós Langer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

László Kóbori

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

7 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Pathology and Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1-10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Malignancy after transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Lung cancer and lung transplantation: a review

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Therapy for primary cardiac tumors: is there a role for heart transplantation?

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Treatment options for other hepatic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Hilar cholangiocarcinoma: current management

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

[Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour].

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Major causes of death among men and women in China

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Diagnosis and treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Molecular targeted therapies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Diagnosis and Treatment of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for hepatocellular carcinoma: the MELD impact.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Strategies for widening liver donor pool.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Ethics and rationale of living-donor liver transplantation in Asia

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Current controversies surrounding liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Does living donation have advantages over deceased donation in liver transplantation?

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Benefit of downsizing hepatocellular carcinoma in a liver transplant population

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

HCC in living donor liver transplantation: can we expand the Milan criteria?

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

Treatment of early hepatocellular carcinoma: Towards personalized therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9441-4

21 January 2018

The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma--epidemiological trends and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary cardiac sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation from live donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary cardiac sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-Line Treatment for Hepatocellular Carcinoma: Resection or Transplantation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for HCC: its role: Eastern and Western perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extending indication: role of living donor liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Milan criteria, up-to-seven criteria, and the illusion of a rescue package for patients with liver cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Living-donor liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful living-related partial liver transplantation to an adult patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-011-9441-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21901276%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37928952&oldid=2201085669"